Skip to content
  • PAD
    • Pounce System
    • DETOUR System
    • DETOUR System Reimbursement
    • DETOUR Professional Education
    • For PAD Patients
    • Find a Doctor
  • AAA
    • AAA
    • ALTO
    • AFX2
    • EVAR for Women
    • EVAR Portfolio Resources
    • Clinical Evidence
    • Procedural Training
  • IFU’s
  • About Us
    • About Us
    • News
    • The Team
    • Careers
      • Internal Applicant Portal
      • External Applicant Portal
    • Investigator Initiated
      Research
    • Contact Us
  • PAD
    • Pounce System
    • DETOUR System
    • DETOUR System Reimbursement
    • DETOUR Professional Education
    • For PAD Patients
    • Find a Doctor
  • AAA
    • AAA
    • ALTO
    • AFX2
    • EVAR for Women
    • EVAR Portfolio Resources
    • Clinical Evidence
    • Procedural Training
  • IFU’s
  • About Us
    • About Us
    • News
    • The Team
    • Careers
      • Internal Applicant Portal
      • External Applicant Portal
    • Investigator Initiated
      Research
    • Contact Us
Back to News
  • June 28, 2018

Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study

PrevPreviousEndologix Appoints Jeffry Fecho as Chief Quality Officer
NextEndologix Appoints Jeffrey S. Brown as Chief Operations OfficerNext
FIND IFU HERE
Youtube Linkedin Twitter
Compliance
Privacy Policy
Safety Information
Anti-Trafficking/Modern Slavery
Carbon Reduction Plan UK
Cookie Policy
Terms & Conditions
Patents

© 2026 Endologix LLC. All rights reserved.

Endologix® products and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability. Prior to use, refer to the “Instructions for Use” for complete and specificindications, contraindications, all warnings and precautions. Rx only.